PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

186 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
141.
Enriori, P.J.* et al.: α-Melanocyte stimulating hormone promotes muscle glucose uptake via melanocortin 5 receptors. Mol. Metab. 5, 807-822 (2016)
142.
Giroud, M.* et al.: miR-125b affects mitochondrial biogenesis and impairs brite adipocyte formation and function. Mol. Metab. 5, 615-25 (2016)
143.
Hausmann, S. & Ussar, S.: Insulin receptor trafficking steers insulin action. Mol. Metab. 5, 253-254 (2016)
144.
Klancic, T. ; Woodward, L.* ; Hofmann, S.M. & Fisher, E.A.*: High density lipoprotein and metabolic disease: Potential benefits of restoring its functional properties. Mol. Metab. 5, 321-327 (2016)
145.
Kleinert, M. et al.: MTORC2 and AMPK differentially regulate muscle triglyceride content via perilipin 3. Mol. Metab. 5, 646-655 (2016)
146.
Kübeck, R.* et al.: Dietary fat and gut microbiota interactions determine diet-induced obesity in mice. Mol. Metab. 5, 1162-1174 (2016)
147.
Mziaut, H. et al.: The F-actin modifier villin regulates insulin granule dynamics and exocytosis downstream of islet cell autoantigen 512. Mol. Metab. 5, 656-68 (2016)
148.
Ordelheide, A.-M. et al.: Granulocyte Colony-Stimulating Factor (G-CSF): A saturated fatty acid-induced myokine with insulin-desensitizing properties in humans. Mol. Metab. 5, 305-316 (2016)
149.
Ost, M.* et al.: Muscle mitochondrial stress adaptation operates independently of endogenous FGF21 action. Mol. Metab. 5, 79-90 (2016)
150.
Quarta, C. & Clemmensen, C.: Unforeseen role for glucocorticoids in combinatorial anti-obesity pharmacology. Mol. Metab. 5, 435-436 (2016)
151.
Raab, S.* et al.: Incretin-like effects of small molecule trace amine-associated receptor 1 agonists. Mol. Metab. 5, 47-56 (2016)
152.
Sánchez-Garrido, M.A. et al.: Fibroblast activation protein (FAP) as a novel metabolic target. Mol. Metab. 5, 1015-24 (2016)
153.
Schäfer, M. et al.: Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia. Mol. Metab. 5, 67-78 (2016)
154.
Schröder, T.* et al.: Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis. Mol. Metab. 5, 283-295 (2016)
155.
Ussar, S. ; Fujisaka, S.* & Kahn, C.R.*: Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome. Mol. Metab. 5, 795-803 (2016)
156.
Ziegler, A.-G. et al.: Primary prevention of beta-cell autoimmunity and type 1 diabetes - the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives. Mol. Metab. 5, 255-262 (2016)
157.
Benazra, M.* et al.: A human beta cell line with drug inducible excision of immortalizing transgenes. Mol. Metab. 4, 916-925 (2015)
158.
Berti, L. et al.: Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes. Mol. Metab. 4, 519-527 (2015)
159.
Dyar, K.A. et al.: The calcineurin-NFAT pathway controls activity-dependent circadian gene expression in slow skeletal muscle. Mol. Metab. 4, 823-833 (2015)
160.
Hansen, J.S.* et al.: Glucagon-to-insulin ratio is pivotal for splanchnic regulation of FGF-21 in humans. Mol. Metab. 4, 551-560 (2015)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... ▶▶ ▶▮